0

Coronary Risk Factors Collection
 141-160 of 200 Articles
ACP Journal Club |  20 October 2009
Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD
Paul Poirier, MD, PhD, FRCPC, FACC, FAHA
Ann Intern Med. 2009;151(8):JC4-5. doi:10.7326/0003-4819-151-8-200910200-02005
ACP Journal Club |  20 October 2009
Review: Preoperative smoking cessation interventions reduce postoperative complications
Andrea Truncali, MD, MPH; Scott Sherman, MD, MPH
Ann Intern Med. 2009;151(8):JC4-4. doi:10.7326/0003-4819-151-8-200910200-02004
ACP Journal Club |  15 September 2009
Rosuvastatin reduced venous thromboembolism in healthy older adults with elevated C-reactive protein levels
Marcel Levi, MD
Ann Intern Med. 2009;151(6):JC3-10. doi:10.7326/0003-4819-151-6-200909150-02010
ACP Journal Club |  15 September 2009
Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes
Lorraine L. Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2009;151(6):JC3-6. doi:10.7326/0003-4819-151-6-200909150-02006
ACP Journal Club |  15 September 2009
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model
Alba DiCenso, RN, PhD; Liz Bayley, MLS; R. Brian Haynes, MD, PhD
Ann Intern Med. 2009;151(6):JC3-2. doi:10.7326/0003-4819-151-6-200909150-02002
ACP Journal Club |  18 August 2009
Bariatric surgery was dominant over conventional therapy for lifetime management of type 2 diabetes in obese patients
Scott Kahan, MD, MPH
Ann Intern Med. 2009;151(4):JC2-15. doi:10.7326/0003-4819-151-4-200908180-02015
ACP Journal Club |  18 August 2009
Bariatric surgery was cost-effective at 2 years for management of type 2 diabetes in obese patients
Scott Kahan, MD, MPH
Ann Intern Med. 2009;151(4):JC2-14. doi:10.7326/0003-4819-151-4-200908180-02014
ACP Journal Club |  18 August 2009
Review: Combining 2 classes of blood pressure–lowering drugs has an approximately additive effect on systolic blood pressure
Alena Shantsila, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2009;151(4):JC2-11. doi:10.7326/0003-4819-151-4-200908180-02011
ACP Journal Club |  18 August 2009
Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction
Peter Liu, MD
Ann Intern Med. 2009;151(4):JC2-9. doi:10.7326/0003-4819-151-4-200908180-02009
ACP Journal Club |  18 August 2009
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk for cardiac events
Michael E. Farkouh, MD
Ann Intern Med. 2009;151(4):JC2-7. doi:10.7326/0003-4819-151-4-200908180-02007
ACP Journal Club |  18 August 2009
Review: Diabetes is not a coronary disease equivalent
Michael E. Farkouh, MD
Ann Intern Med. 2009;151(4):JC2-6. doi:10.7326/0003-4819-151-4-200908180-02006
ACP Journal Club |  18 August 2009
Review: Intensive insulin therapy increases risk for hypoglycemia but not mortality in critically ill adults
Michelle A. Kovalaske, MD; Gunjan Y. Gandhi, MD, MSc
Ann Intern Med. 2009;151(4):JC2-4. doi:10.7326/0003-4819-151-4-200908180-02004
ACP Journal Club |  21 July 2009
High consumption of red meat and processed meat was associated with increased risk for mortality
Joel Schectman, MD
Ann Intern Med. 2009;151(2):JC1-15. doi:10.7326/0003-4819-151-2-200907210-02015
ACP Journal Club |  21 July 2009
Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes
Vivian Fonseca, MD
Ann Intern Med. 2009;151(2):JC1-12. doi:10.7326/0003-4819-151-2-200907210-02012
ACP Journal Club |  21 July 2009
Review: Nicotine gum and varenicline, but not behavioral interventions, reduce relapse in persons who have stopped smoking
Charles J. Bentz, MD, FACP
Ann Intern Med. 2009;151(2):JC1-11. doi:10.7326/0003-4819-151-2-200907210-02011
ACP Journal Club |  16 June 2009
“Pragmatic” clinical trials: from whose perspective?
Paul J. Karanicolas, MD; Victor M. Montori, MD; Holger J. Schünemann, MD, PhD; et al.
Ann Intern Med. 2009;150(12):JC6-2. doi:10.7326/0003-4819-150-12-200906160-02002
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  19 May 2009
Intensive primary care treatment reduced cardiovascular risk factors at 1 year in screen-detected type 2 diabetes
C. Raina Elley, MD; Tim Kenealy, MD, PhD
Ann Intern Med. 2009;150(10):JC5-9. doi:10.7326/0003-4819-150-10-200905190-02009
ACP Journal Club |  19 May 2009
Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
Simon W. Rabkin, MD
Ann Intern Med. 2009;150(10):JC5-8. doi:10.7326/0003-4819-150-10-200905190-02008
ACP Journal Club |  19 May 2009
What kind of randomized trials do patients and clinicians need?
Merrick Zwarenstein, MBBCh, MSc; Shaun Treweek, PhD
Ann Intern Med. 2009;150(10):JC5-2. doi:10.7326/0003-4819-150-10-200905190-02002
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)